Table 13 Cross-validation performance of BioEGRE on GAD and EU-ADR
Fold | GAD | EU-ADR | ||||
|---|---|---|---|---|---|---|
p (%) | r (%) | f (%) | p (%) | r (%) | f (%) | |
1 | 79.55 | 87.19 | 83.19 | 81.48 | 84.62 | 83.02 |
2 | 79.21 | 86.71 | 82.79 | 81.84 | 83.33 | 82.58 |
3 | 79.33 | 87.30 | 83.12 | 80.67 | 85.11 | 82.83 |
4 | 78.97 | 86.67 | 82.64 | 81.48 | 84.52 | 82.97 |
5 | 79.75 | 87.21 | 83.31 | 81.75 | 85.34 | 83.51 |
6 | 79.33 | 87.67 | 83.29 | 81.98 | 84.76 | 83.35 |
7 | 78.82 | 88.11 | 83.21 | 80.45 | 84.36 | 82.36 |
8 | 79.01 | 87.42 | 83.00 | 80.10 | 84.57 | 82.27 |
9 | 80.01 | 86.33 | 83.05 | 81.33 | 90.15 | 85.51 |
10 | 78.21 | 86.52 | 82.16 | 80.36 | 83.02 | 81.67 |
Ove | 79.21 ± 0.51 | 87.11 ± 0.55 | 82.98 ± 0.36 | 81.14 ± 0.68 | 84.98 ± 1.95 | 83.00 ± 1.03 |